Abstract
In the present study, we prepared a series of 21 chromone carboxamide derivatives bearing diverse amide side chains. Their potency to inhibit the proliferation of breast (MCF-7), ovarian (OVCAR and IGROV), and colon (HCT-116) cancer cell lines, was evaluated in vitro using the MTT assay. Among these compounds, 13 showed promising cytotoxic activity against at least one cancer cell line with IC50 in the range 0.9–10 μM. Our compounds were also screened for their anti-inflammatory activity as putative inhibitors of 5-lipoxygenase.
Structure-activity relationships studies on our chromone carboxamide derivatives revealed that the presence of a 6-fluoro substituent on the chromone nucleus (R1) or propyl and 3-ethylphenyl groups on the amide side chain (R2) has a positive impact on the cytotoxic activity. In terms of the anti-inflammatory activity, hydrophilic chromone carboxamide derivatives showed greater 5-lipoxygenase inhibition.
The physico-chemical properties of chromone carboxamides are in accordance with the general requirements of drug development process and ligand efficiency values allow further structure optimization, with compound 4b as a lead.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs00044-016-1691-y/MediaObjects/44_2016_1691_Sch1_HTML.gif)
Similar content being viewed by others
References
Abad-Zapatero C (2007) Ligand efficiency indices for effective drug discovery. Expert Opin Drug Dis 2:469–488
Aggarwal BB, Shishodia S, Sandur SK, Pandey MK, Sethi G (2006) Inflammation and cancer: How hot is the link? Biochem Pharmacol 72(11):1605–1621
Auffret G, Labaied M, Frappier F, Rasoanaivo P, Grellier P, Lewin G (2007) Synthesis and antimalarial evaluation of a series of piperazinyl flavones. Bioorg Med Chem Lett 17(4):959–963
Balkwill FR, Mantovani A (2012) Cancer-related inflammation: common themes and therapeutic opportunities. Semin Cancer Biol 22(1):33–40
Barve V, Ahmed F, Adsule S, Banerjee S, Kulkarni S, Katiyar P, Anson CE, Powell AK, Padhye S, Sarkar FH (2006) Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells. J Med Chem 49(13):3800–3808
Baylac S, Racine P (2003) Inhibition of 5-lipoxygenase by essential oils and other natural fragrant extracts. Int J Aromather 13(2-3):138–142
Bekir J, Mars M, Souchard JP, Bouajila J (2013) Assessment of antioxidant, anti-inflammatory, anti-cholinesterase and cytotoxic activities of pomegranate (Punica granatum) leaves. Food Chem Toxicol 55:470–475
Bhatnagar S, Sahi S, Kackar P, Kaushik S, Dave MK, Shukla A, Goel A (2010) Synthesis and docking studies on styryl chromones exhibiting cytotoxicity in human breast cancer cell line. Bioorg Med Chem Lett 20(16):4945–4950
Bray F, Jemal A, Grey N, Ferlay J, Forman D (2012) Global cancer transitions according to the human development index (2008–2030): A population-based study. Lancet Oncol 13(8):790–801
Budzisz E, Graczyk-Wojciechowska J, Zieba R, Nawrot B (2002) A new series of 2-substituted 3-phosphonic derivatives of chromone. Part II. Synthesis, in vitro alkylating and in vivo antitumour activity. New J Chem 26(12):1799–1804
do Rocio Andrade Pires A, Lecerf-Schmidt F, Guragossian N, Pazinato J, Gozzi GJ, Winter E, Valdameri G, Veale A, Boumendjel A, Di Pietro A, Pérès B (2016) New, highly potent and non-toxic, chromone inhibitors of the human breast cancer resistance protein ABCG2. Eur J Med Chem 122:291–301
Ellis GP, Shaw D (1972) Benzopyrones. 7. Synthesis and antiallergic activity of some 2-(5-tetrazolyl)chromones. J Med Chem 15(8):865–867
Gaspar A, Matos MJ, Garrido J, Uriarte E, Borges F (2014) Chromone: a valid scaffold in medicinal chemistry. Chem Rev 114(9):4960–4992
Gaspar A, Reis J, Kachler S, Paoletta S, Uriarte E, Klotz K-N, Moro S, Borges F (2012) Discovery of novel A3 adenosine receptor ligands based on chromone scaffold. Biochem Pharmacol 84(1):21–29
Gaspar A, Reis J, Matos MJ, Uriarte E, Borges F (2012) In search for new chemical entities as adenosine receptor ligands: Development of agents based on benzo-g-pyrone skeleton. Eur J Med Chem 54(0):914–918
Gaspar A, Silva T, Yanez M, Vina D, Orallo F, Ortuso F, Uriarte E, Alcaro S, Borges F (2011) Chromone, a privileged scaffold for the development of monoamine oxidase inhibitors. J Med Chem 54(14):5165–5173
Gaspar A, Teixeira F, Uriarte E, Milhazes N, Melo A, Cordeiro MNDS, Ortuso F, Alcaro S, Borges F (2011) Towards the discovery of a novel class of monoamine oxidase inhibitors: structure–property–activity and docking studies on chromone amides. Chem Med Chem 6(4):628–632
Hopkins, AL, Keserü, GM, Leeson, PD, Rees DC, and Reynolds CH (2014) Nature Rev 13: 105-121.
Keri RS, Budagumpi S, Pai RK, Balakrishna RG (2014) Chromones as a privileged scaffold in drug discovery: A review. Eur J Med Chem 78(0):340–374
Khan KM, Ambreen N, Mughal UR, Jalil S, Perveen S, Choudhary MI (2010) 3-Formylchromones: potential antiinflammatory agents. Eur J Med Chem 45(9):4058–4064
Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Delivery Rev 23:3–25
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65(1-2):55–63
Nam DH, Lee KY, Moon CS, Lee YS (2010) Synthesis and anticancer activity of chromone-based analogs of lavendustin A. Eur J Med Chem 45(9):4288–4292
Pan S-T, Li Z-L, He Z-X, Qiu J-X, Zhou S-F (2016) Molecular mechanisms for tumour resistance to chemotherapy. Clin Exp Pharmacol Physiol 43:723–737
Payard M (1973) Nouveau mode de préparation du chlorure d’acide chromone carboxylique-2. Bull Soc Chim Fr 7-8:2392–2394
Payard M, Paris J, Tronche P (1974) Synthèse et dissociation d’acides chromone-carboxyliques-2 et d’acides chromone-carbohydroxamiques-2. Bull Soc Chim Fr 16(3):157
Redda KK, Gangapuram M, Ghaffari MA, Eyunni S (2014) Synthesis of substituted chromone-2-phenylcarboxamides as anti-breast cancer agents. Cancer Res 74(19):1
Shimizu T, Radmark O, Samuelsson B (1984) Enzyme with dual lipoxygenase activities catalyzes leukotriene A4 synthesis from arachidonic acid. Proc Natl Acad Sci U.S.A. 81(3):689–693
Soumaoro LT, Iida S, Uetake H, Ishiguro M, Takagi Y, Higuchi T, Yasuno M, Enomoto M, Sugihara K (2006) Expression of 5-lipoxygenase in human colorectal cancer. World J Gastroenterol 12(39):6355–6360
Thanigaimalai P, Le Hoang TA, Lee K-C, Sharma VK, Bang S-C, Yun JH, Roh E, Kim Y, Jung S-H (2010) Synthesis and evaluation of novel chromone analogs for their inhibitory activity against interleukin-5. Eur J Med Chem 45(6):2531–2536
Valdameri G, Genoux-Bastide E, Peres B, Gauthier C, Guitton J, Terreux Rl, Winnischofer SMB, Rocha MEM, Boumendjel A, Di Pietro A (2012) Substituted chromones as highly potent nontoxic inhibitors, specific for the breast cancer resistance protein. J Med Chem 55(2):966–970
World Health Organization. (2013) Press release no. 223. www.molinspiration.com. Accessed 12 Dec 2013.
Acknowledgments
We are thankful to Laurent Amielet, Christelle Récochet-Gueriot and Sylvie Cazaux for technical support. We are grateful to the “VLM” association for financial support.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Bousejra-ElGarah, F., Lajoie, B., Souchard, JP. et al. Synthesis and evaluation of chromone-2-carboxamide derivatives as cytotoxic agents and 5-lipoxygenase inhibitors. Med Chem Res 25, 2547–2556 (2016). https://doi.org/10.1007/s00044-016-1691-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-016-1691-y